The Complete Ingredient Breakdown
Isatis Root
The bottom line
Bottom Line
What is Isatis Root?
Of 18 samples of ban lan gen bought across all 18 districts of Hong Kong for a 2025 PLoS One study, 17 were DNA-identified as Strobilanthes, a different plant. The name travels further than the botany. In Chinese herb shops, "ban lan gen" (板蓝根, roughly "indigo-blue root") can mean either of two unrelated plants, and the name alone does not tell a buyer which one is inside.
The official plant is Isatis indigotica Fort., a biennial of the cabbage and mustard family, Brassicaceae. China's 2020 pharmacopoeia defines the drug Isatidis Radix as its dried root, assigns it the actions of clearing heat, resolving toxin, cooling the blood and benefiting the throat, and sets a dose of 9 to 15 g. The 2025 Hong Kong study treats Isatis indigotica as a synonym of Isatis tinctoria, the European dyer's woad, which is why some papers and labels use one name and some the other. The leaf of the same plant is a separate drug, da qing ye (Isatidis Folium). According to a 2022 review in the American Journal of Chinese Medicine (Wong and colleagues), the plant was a staple of Chinese indigo dye manufacture until the end of the 17th century. The Hong Kong study team dates medicinal use of the root to the Song dynasty, around 1000 AD, and names Gansu province as the largest growing area, at about 7,000 tons a year. The Hong Kong Chinese Materia Medica Standards specify a root collected in autumn and dried in the sun. Hong Kong's Department of Health describes the finished drug as cylindrical, slightly twisted, 10 to 20 cm long and 0.5 to 1 cm thick, pale grayish-yellow outside, tasting slightly sweet, then bitter and astringent.
The second plant is nan ban lan gen (南板蓝根, "southern ban lan gen"), the rhizome and root of Strobilanthes cusia, which China's pharmacopoeia still lists under its older name Baphicacanthus cusia (Nees) Bremek. It belongs to the acanthus family, Acanthaceae, and is no close relative of Isatis. A 2023 study in the journal Chinese Medicine (Li and colleagues, Macau University of Science and Technology) reports that the pharmacopoeia first carried it as one of the sources of ban lan gen, alongside Isatis, and has listed it as an independent drug since 1995. Hong Kong's Department of Health, in an identification note revised in December 2021, draws on the Ming dynasty Compendium of Materia Medica: the ban lan with leaves like pakchoi is Isatis, while the one with leaves like sow thistle is the southern plant, whose underground parts southern regions still use as ban lan gen.
Common Names
Isatis root, indigowoad root, woad root, dyer's woad root (for Isatis tinctoria), ban lan gen or banlangen, bei ban lan gen ("northern ban lan gen," used to separate it from the southern plant), Isatidis Radix, Radix Isatidis. Names that point somewhere else: nan ban lan gen (Strobilanthes cusia root), da qing ye (Isatis leaf), nan da qing ye (Strobilanthes leaf), and qing dai or indigo naturalis, a processed blue pigment powder made from the leaves and stems of Strobilanthes cusia, Polygonum tinctorium or Isatis indigotica (see Special Considerations).
Primary Active Compounds
Chen and colleagues (Journal of Ethnopharmacology, 2022) count 304 compounds reported from the root and 142 from the leaf. The compound that defines the root for regulators is goitrin, a sulfur-containing alkaloid that exists as two mirror-image forms, goitrin and epigoitrin; China's pharmacopoeia assays them together as (R,S)-goitrin, and Hong Kong's standard assays epigoitrin. They form from two glucosinolates, progoitrin and epiprogoitrin, when the plant's own enzyme myrosinase acts on them, and amounts vary widely. The one genuine Hong Kong retail sample held 0.023% epigoitrin, while a 2014 drying study by Tan and colleagues (Zhong Yao Cai) measured 3.85 to 5.20 mg per g, which is 0.38% to 0.52%, in its own samples, along with 0.70 to 1.03 mg per g of uridine. The root also contains indole and quinazoline alkaloids (indirubin, indigo, tryptanthrin, 4(3H)-quinazolinone), lignans such as clemastanin B, nucleosides such as adenosine, amino acids including arginine, polysaccharides, and a family of sulfur-rich alkaloids, the isatithioetherins and isatithiopyrins, described by Guo and colleagues in 2018. The southern root has a different profile: a 2023 analysis identified 73 compounds in it, 50 of them alkaloids, led by benzoxazinone glucosides and 2-benzoxazolinone, plus acteoside, indigo and indirubin, and found only 17 compounds shared with 84 identified in Isatis root.
Key Note
Goitrin is both the root's quality marker and the reason to ask about the thyroid. It is the same antithyroid compound found in some brassica vegetables, and Felker and colleagues (Nutrition Reviews, 2016) cite human data in which 194 micromoles of goitrin, about 25 mg, inhibited the thyroid's uptake of radioactive iodine while 77 micromoles, about 10 mg, did not. No study of ban lan gen and thyroid function in people was located for this issue.
Isatis root is a cabbage-family root sold under a name it shares with an unrelated southern shrub, supported by laboratory antiviral work and one registered placebo-controlled influenza trial that never posted results.
Scan any Isatis Root product in seconds with the free NutrientWise app: App Store · Google Play
What the Label Won't Tell You
"Ban lan gen" names two unrelated plants, and the research and the shelf often mean different ones. China's 2020 pharmacopoeia reserves the name for the root of Isatis indigotica, a cabbage-family plant, and has listed nan ban lan gen, the rhizome and root of Strobilanthes cusia (Baphicacanthus cusia), an acanthus-family shrub, as a separate drug since 1995. A 2023 comparison found 84 compounds in Isatis root and 73 in Strobilanthes root, with only 17 in common. When a 2025 PLoS One team DNA-tested ban lan gen bought in all 18 Hong Kong districts, 17 samples were Strobilanthes, and none of those 17 showed the goitrin marker the official standards test for. Most of the antiviral and pharmacokinetic papers, and the one registered influenza trial, name Isatis. In the US, the NIH label database returns 157 "isatis" labels; many now name species and part, yet its entry for Seven Forests' "Isatis 6" records the herb as Baphicacanthus leaf.
Primary Functions & Benefits
In Chinese medicine ban lan gen is a cooling, "heat-clearing" herb for fever, sore throat and influenza-like illness, and the 2022 Chen review counts 39 Chinese patent medicines containing the root, the leaf or both. China's medicines regulator had 977 approvals for ban lan gen granules, 146 for compound ban lan gen granules and 37 for ban lan gen injection on its database in November 2022, as reported by the business outlet Jiemian. Popularity is not evidence, and the human evidence is thin.
Influenza: the one registered randomized trial
Researchers at the Guangzhou Institute of Respiratory Disease designed a double-blind, double-dummy trial (Li and colleagues, Trials, 2015; NCT02232945) comparing ban lan gen granules with oseltamivir and with placebo in adults aged 18 to 65 with laboratory-confirmed influenza A or B, a temperature of at least 38.0 °C, and symptoms that began within 36 hours. The granule arm took 2 bags of 10 g twice daily for 5 days, with follow-up on days 1, 3, 5, 7 and 21; the oseltamivir arm took 75 mg twice daily. The sponsor was Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company, which packaged the trial drugs. The plan was 177 patients. By June 2014, 50 had completed treatment and follow-up, and the authors wrote that the 36-hour window "made patient recruitment quite difficult." The ClinicalTrials.gov record was last updated in March 2016, now shows the status as unknown with the last known status recruiting, and has no results posted. No published results were located. The protocol itself states that earlier clinical studies of the granules for pharyngitis, upper respiratory infection and H1N1 influenza were not evidence-based clinical trials.
Radiation mucositis: 20 patients
You and colleagues (Journal of Alternative and Complementary Medicine, 2009) randomized 20 patients receiving radiotherapy for head and neck cancer in Taiwan: 11 gargled and then swallowed an indigowood root preparation, and 9 used saline. The root group had less severe mucositis (p = 0.01), less loss of appetite (p = 0.002) and less difficulty swallowing (p = 0.002), and serum interleukin-6, an inflammatory signal, was lower in weeks 1, 5 and 7. The number of treatment breaks did not differ significantly (p = 0.06): 4 of 11 root patients and 2 of 9 controls completed radiotherapy without a rest. The authors named the plant Isatis indigotica and proposed indirubin as the active compound; the abstract does not describe how the material was authenticated, and the 2023 comparative study notes that the southern root contains more indirubin than Isatis root.
Antiviral activity in the laboratory
Most of the root's reputation rests here. Nie and colleagues (Journal of Ethnopharmacology, 2020) isolated progoitrin, epiprogoitrin, goitrin and epigoitrin from Isatis root and found that all four inhibited an H1N1 influenza A virus in dog kidney cells and in fertilized eggs, in the order progoitrin, then goitrin, epigoitrin and epiprogoitrin, by attaching to the viral envelope. Guo and colleagues (Acta Pharmaceutica Sinica B, 2018) reported that two of the root's sulfur alkaloids inhibited an H3N2 influenza strain at 0.60 and 1.92 micromolar, herpes simplex virus 1 at 3.70 and 2.87 micromolar, and one inhibited coxsackievirus B3 at 0.71 micromolar. These are purified compounds in cell culture. A 2014 screen (Ma and colleagues) found that arginine and goitrin from the root bound influenza neuraminidase, but their half-inhibitory concentrations were 1.16 and 1.20 g per liter, about 1.2 mg per mL, far above any blood level reported in the studies located. Reviews also list activity against hepatitis B, mumps, cytomegalovirus and coxsackievirus (Chen and colleagues, Journal of Pharmacy and Pharmacology, 2021) and respiratory syncytial virus (the 2022 Chen review), almost entirely from cell and animal work.
Immune and anti-inflammatory effects, mostly in animals
4(3H)-quinazolinone, one of the root compounds found in blood after dosing, damped interferon-beta release from mouse macrophages infected with respiratory syncytial virus at 0.3125 to 1.25 micromolar, less strongly than the antiviral drug ribavirin (He and colleagues, International Immunopharmacology, 2017). Much of the polysaccharide research is veterinary, including a 288-hen feeding trial at 200 to 1,000 g of polysaccharide per metric ton of feed (Research in Veterinary Science, 2023), co-authored by staff of the company that sponsored the influenza trial. These studies say something about animal husbandry and little about a person with a sore throat.
Which plant the comparisons favor
The two literatures disagree about which root is the better antiviral, and each team's summary favors its own plant. The 2023 Chinese Medicine paper, written about the southern root, cites earlier work finding that nan ban lan gen inhibited influenza hemagglutination while Isatis root showed "almost no obvious inhibition activity." The 2025 Hong Kong team summarizes a comparison in which both roots had anti-influenza activity, Isatis root more for direct inhibition and prevention and the southern root more after infection. Neither claim rests on a human trial.
Forms & Standardization
Standardization exists on paper for the Isatis root and is largely absent for the southern root. None of the US labels examined for this issue stated a marker content.
Dried root and decoction pieces
China's 2020 pharmacopoeia requires the dried root to contain at least 0.020% (R,S)-goitrin, and sliced decoction pieces at least 0.030%. The Hong Kong Chinese Materia Medica Standards set a higher limit for the whole root: at least 0.029% epigoitrin on a dried basis by HPLC, a five-peak HPLC fingerprint, water-soluble extractives of at least 34.0% and ethanol-soluble extractives of at least 31.0%, total ash no more than 7.0%, acid-insoluble ash no more than 1.0%, water no more than 15.0% and foreign matter no more than 1.0%, with heavy metals, pesticides, mycotoxins and sulfur dioxide required to meet general limits. The single genuine Hong Kong retail sample, at 0.023%, passed the mainland whole-root limit and failed the Hong Kong one; judged as slices, it would also fall below the mainland 0.030% limit.
Granules
Ban lan gen granules (Banlangen Keli) are the mass-market form in China, dissolved in hot water. The Guangzhou trial used 10 g bags. Jiemian reports that in March 2018 the Chinese Pharmacopoeia Commission proposed adding a content assay to the granule standard, suggesting the granule standard at that time had none. Compound ban lan gen granules add other herbs.
Injection
Ban lan gen injection had 37 approvals in China as of November 2022. Its label now carries an anaphylactic shock warning (see Potential Negatives).
Supplements sold in the US
A search of the NIH Dietary Supplement Label Database for "isatis" returns 157 labels, single herbs and blends. Examples:
Single-herb liquids such as Herbal Terra and Hawaii Pharm "Ban Lan Gen," which list Isatis tinctoria dried root: species and part named, no marker.
Thorne's Isatis, a 350 mg capsule of 4:1 dyer's woad root extract, recorded as off the market since December 2019.
Health Concerns Isatis Cooling, Astra Isatis and Isatis Gold: current versions are capsules, about 1,830 to 1,960 mg of proprietary blend per 3 capsules, listing Isatis extract (pinyin "Da Qing Ye & Ban Lan Gen," leaf and root) with no species and no Isatis amount. Astra Isatis adds astragalus, kelp and licorice; Isatis Gold adds echinacea, platycodon, goldenseal and ligusticum; the 2019 Isatis Cooling label lists 12 ingredients, one of them oyster shell.
Seven Forests "Isatis 6": the database records its first ingredient, da qing ye (alternate name "Isatis"), as Baphicacanthus leaf, the southern plant, at 25% of the formula.
The southern root
China's pharmacopoeia sets no assay marker for nan ban lan gen. Identity is checked by thin-layer chromatography for indigo and indirubin, with ethanol-soluble extractives of at least 13.0%, water no more than 12.0% and total ash no more than 10.0%. The 2023 Chinese Medicine study proposed 2-benzoxazolinone and acteoside as markers at a minimum of 0.010% each, after finding 0.007% to 0.062% 2-benzoxazolinone and 0.005% to 0.546% acteoside across 11 batches, about a 100-fold spread for acteoside.
What the studies used
The influenza trial used industry granules made to the pharmacopoeia's requirements. The mucositis trial used an "indigowood root" preparation of unstated authentication. The antiviral compound work used chemicals isolated from Isatis root, and the rat pharmacokinetic work used an Isatis root extract at 0.1 to 1 g per kg. European research on woad by Matthias Hamburger and collaborators, including a 20-volunteer skin irritation study (Heinemann and colleagues, Planta Medica, 2004), used Isatis tinctoria leaf extracts, not root.
Food Sources
Ban lan gen supplies no nutrient and is not a routine food in Western diets. Chen and colleagues describe the root and leaf as traditional "edible-medicinal" herbs in China, and the Hong Kong team lists herbal mouthwashes, floral teas and hand sanitizers among products that contain it. This section covers exposure, mostly to goitrin.
Goitrin in brassica vegetables, for comparison
Isatis is a crucifer, and goitrin forms in brassica vegetables from the same precursor, progoitrin. Felker and colleagues (2016) conclude that collards, Brussels sprouts and some Russian kale contain enough goitrin to potentially reduce iodine uptake by the thyroid, while turnip tops, commercial broccoli, broccoli rabe and kale of the species Brassica oleracea contain less than 10 micromoles per 100 g serving and carry minimal risk. Cooking lowers goitrin: a 2023 study in Foods (Panduang and colleagues) recommended steaming cabbage at 80 to 100 °C for 4 minutes to reduce goitrin while preserving isothiocyanates.
What a dose of root could contain
No measurement of goitrin in a brewed cup or a granule dose was located, so this is arithmetic. At the 0.023% found in the genuine Hong Kong sample, 15 g of root, the top of the pharmacopoeia range, would hold about 3.5 mg of epigoitrin, roughly 27 micromoles. At the 0.52% top value in the 2014 drying study, the same 15 g would hold about 78 mg, roughly 600 micromoles. The first figure sits below the 77 micromoles that did not affect thyroid iodine uptake in Felker's summary; the second is about three times the 194 micromoles that did. Goitrin dissolves in hot water, which is how the Hong Kong assay extracts it, but how much of it a home decoction recovers, and whether epigoitrin and goitrin are equally antithyroid, were not established in the sources located. The 20-fold spread between those two measurements is the practical problem.
Goitrin already in the root
In rats, (R,S)-goitrin from an oral root extract was absorbed, with 56.33% bioavailability (see How Isatis Root Works). Whether the root's glucosinolate precursors are converted to more goitrin in the human gut was not established in the sources located for this issue.
The southern root
Strobilanthes is not a crucifer, and goitrin was not detected in any of the 17 Strobilanthes samples in the Hong Kong study. The goitrin question applies to Isatis root, not to nan ban lan gen.
Who Should Take Isatis Root
No group has been shown in a published, adequately sized trial to benefit from ban lan gen. The realistic users are:
Adults using Chinese medicine under a trained practitioner for a short course during a sore throat or feverish cold, who accept that the evidence is traditional and laboratory-based.
Buyers who specifically want Isatis root rather than the southern plant, who need a product naming Isatis indigotica or Isatis tinctoria and the plant part.
Ban lan gen has not been shown to treat or prevent influenza, COVID-19, hepatitis or any other infection in people, and it is no replacement for an antiviral when one is indicated. In January 2020, China's National Health Commission publicly denied that ban lan gen prevents COVID-19, as reported by Jiemian.
Who Should AVOID or Use Caution
Contraindications
Ban lan gen injection outside a hospital setting. In November 2022 China's National Medical Products Administration ordered its label to warn that adverse reactions include anaphylactic shock, that it be used only in medical institutions able to provide rescue treatment by staff trained in anaphylaxis rescue, and that it be stopped at once if an allergic or serious reaction occurs, as reported by Jiemian. Injectable herbal products have no place in self-care.
Pregnancy and breastfeeding. No reproductive or lactation study of either plant was located. Older Health Concerns tablet labels stated the products were not intended for pregnant women; the current capsule labels instead say to consult a practitioner first if pregnant or nursing. Avoid it.
Infants and young children, without a clinician. No pediatric safety study was located, and the Guangzhou trial enrolled only adults aged 18 to 65. Isatis is nonetheless sold for children in the US: Source Naturals Wellness Herbal Kids, a multi-herb liquid containing it, is labeled only as not for children under 1 year.
Anyone who has reacted to ban lan gen or to a multi-herb product containing it.
Use Caution
Hypothyroidism, goiter, low iodine intake, or treatment with levothyroxine or an antithyroid drug such as methimazole. Isatis root contains goitrin in amounts that vary about 20-fold between published measurements, and the high end could plausibly exceed the dose shown to reduce thyroid iodine uptake. This is an inference; no human thyroid study of the herb exists in the literature located. Health Concerns Astra Isatis also contains kelp (kun bu), a source of iodine that can itself disturb thyroid function, and licorice, which carries its own blood pressure and potassium cautions.
A history of allergic or "allergy-like" reactions to herbal medicines. Isatis root extract caused histamine-dependent vascular leakage in mice and activated complement in human serum, a reaction that does not need IgE antibodies (Gao and colleagues, Frontiers in Pharmacology, 2019).
Flu-like illness in anyone at high risk of complications, including older adults, pregnant people and those with heart or lung disease. Waiting to see whether ban lan gen works can use up the window in which antivirals help most.
Organ transplant recipients and others on immunosuppressants. A fatty acid compound isolated from the root, combined with tacrolimus, prolonged heart graft survival in mice (Immunology and Cell Biology, 2020), while the polysaccharides stimulate immune cells. Which way a whole-root product pushes is unknown.
Multi-herb products. Isatis Gold also contains goldenseal, which carries its own interaction profile, and the 12-ingredient blends contain ingredients the buyer may not have chosen.
Critical Safety Point
Ban lan gen is not a substitute for influenza treatment: its only registered flu trial never reported results, and the injectable form carries an anaphylactic shock warning in China. Loose root bought by its Chinese name may be a different plant altogether, as 17 of 18 Hong Kong samples were.
Recommended Dosages
No dose of either plant has been established by an adequately sized trial. The figures below are pharmacopoeia, label and research amounts, not recommendations.
Dried root, as a decoction
China's 2020 pharmacopoeia gives 9 to 15 g for Isatidis Radix. It gives the same 9 to 15 g for nan ban lan gen, which can make the two look interchangeable on paper; they are different plants with different chemistry.
Granules
The Guangzhou trial used 2 bags of 10 g twice daily, 40 g of granules a day, for 5 days, which its authors said followed the dose set by the Chinese regulator. That was a research dose in confirmed influenza, and its results were never published.
Extract capsules
Thorne's Isatis, off the market since 2019, directed 1 capsule of 350 mg 4:1 root extract two to three times daily. Several current single-herb root products are liquid extracts whose labels state no goitrin content.
Multi-herb capsules
Health Concerns' current capsule blends direct 3 capsules three times daily between meals (an older Isatis Gold tablet label said every 2 to 4 hours), without stating how much Isatis each contains.
Injection
Only in a medical facility able to treat anaphylaxis, as the 2022 label warning requires.
Duration
Ban lan gen is traditionally used for days, during an acute illness. The trial ran 5 days, and its authors' own safety argument was that the granules were used "only for 5 days in the acute phase." No study of use beyond a few weeks was located, and the goitrin content gives a specific reason not to take it daily for months.
Timing & Administration
The Guangzhou trial gave the granules 30 minutes after meals and enrolled only patients within 36 hours of symptom onset, on the theory that the root acts early in infection; no result tested that theory. Decoctions are traditionally simmered from the sliced root, and the mucositis trial had patients gargle the preparation over the irradiated mouth and then swallow it. Anyone taking levothyroxine should keep to their usual routine and tell their prescriber before adding a goitrin-containing herb.
Timeline of Effects
Influenza (planned, never reported)
The Guangzhou design measured time to symptom relief and time to fever resolution over 5 days of treatment, with follow-up to day 21. No outcome data are public.
Radiation mucositis
Interleukin-6 was lower in the root group in weeks 1, 5 and 7 of radiotherapy, and the mucositis, appetite and swallowing differences were assessed across the treatment course in 20 patients.
Absorption in rats
Tang and colleagues (Fitoterapia, 2025) gave rats Isatis root extract at 0.1, 0.3 and 1 g per kg and measured (R,S)-goitrin in blood. Exposure rose with dose, oral bioavailability was 56.33%, about 56% of the dose was excreted in urine, plasma protein binding was 13% to 16.4% across species, and goitrin reached the adrenal glands, thymus, lymph nodes, liver, spleen and gut. Exposure was higher from the extract than from the same amount of pure goitrin. No human pharmacokinetic study was located.
When to stop and reassess
A sore throat or cold that is not improving within a few days, a fever above 38.5 °C, breathing difficulty, or symptoms in a high-risk person need medical assessment. China's 2021 label for over-the-counter compound ban lan gen granules advises seeing a doctor for fever above 38.5 °C, as reported by Jiemian. Any hives, swelling or wheeze after a dose means stopping at once.
Benefits of Taking Isatis Root
The documented benefits are small and mostly preclinical:
Purified root compounds inhibit influenza A, herpes simplex and coxsackie viruses in cell culture, at concentrations not shown to occur in people.
Root extracts and polysaccharides modulate immune and inflammatory signals in animal and cell studies.
The only human result, a 20-patient mucositis trial, is covered under Research Status & Evidence Quality and is not a basis for self-treatment during radiotherapy.
Centuries of use for feverish sore throats in Chinese medicine are history. They have not been converted into a published human efficacy result.
Potential Negatives & Side Effects
Injection
China's regulator required ban lan gen injection labels to state that adverse reactions include anaphylactic shock, according to the November 2022 Jiemian report of the announcement. The mechanism has been studied in a related product. Gao and colleagues (2019) traced the immediate hypersensitivity reactions of Qingkailing injection, a multi-ingredient product, to its Isatis root component: the root extract activated complement C3 in human serum at a half-effective concentration of 218.6 micrograms per mL and caused histamine-dependent vascular leakage in mice, a "pseudoallergy" that needs no prior sensitization. A nested case-control study of 18 patients with Qingkailing-induced anaphylaxis and 72 matched controls found higher IgE, IgG, interleukin-4 and histamine in the cases, and its authors concluded the reactions were type I, IgE-mediated allergy (Zhao and colleagues, 2011), so the mechanism evidence is mixed.
Oral products
Adverse event data for oral ban lan gen are sparse in the English literature. The 2021 change that moved compound ban lan gen granules from prescription to over-the-counter status in China added adverse reactions to the label: diarrhea, abdominal pain, nausea, vomiting, rash, dizziness and allergic reactions, as reported by Jiemian. Neither the mucositis trial abstract nor the influenza protocol reports adverse event counts for the root.
Wrong plant, wrong effects
The Hong Kong study found one ban lan gen sample mixed with bai xian pi (Dictamnus dasycarpus root bark), an unrelated herb used for eczema-type skin complaints, and one da qing ye sample made entirely of Blumea balsamifera (ai na xiang). Bai xian pi has been linked to drug-induced liver injury in clinical reports, and its furan-containing constituents damage the liver in mice (PMID 37446707, 32484342 and 41275938). A buyer who believes they are taking Isatis may be taking something with a different safety record, including a liver hazard.
Deficiency Symptoms
What Isatis root addresses
No deficiency state exists. The body has no requirement for any compound in either plant, and no blood test can show a need.
Bottom line
Ban lan gen fills no nutritional gap, and going without it causes nothing noticeable.
Toxicity Symptoms
At high intake
No human case of poisoning from oral Isatis root was located for this issue. The recorded serious harm is anaphylaxis from the injectable form. Animal toxicity data come mainly from multi-ingredient injections such as Qingkailing given intravenously, which say little about a cup of decoction. The plausible chronic concern for oral Isatis root is thyroid suppression from goitrin, which is modeled, not observed. For the related pigment indigo naturalis, made from the leaves and stems of the same group of plants, the human record is real: a Japanese ulcerative colitis trial of 86 patients was stopped after pulmonary arterial hypertension was reported in a patient who had used self-purchased indigo naturalis for 6 months, and mild liver dysfunction occurred in 10 trial patients taking it (Naganuma and colleagues, Gastroenterology, 2018).
Signs to reduce or stop
Hives, flushing, swelling of the lips or throat, wheeze or faintness after any form, which need emergency care; in the US, call 911.
Neck swelling, unusual tiredness, feeling cold, weight gain or slowed thinking during prolonged use, which warrant a thyroid check.
Breathlessness on exertion, chest discomfort or ankle swelling in anyone taking indigo naturalis (qing dai), which can signal pulmonary hypertension.
Abdominal pain or bloody diarrhea on indigo naturalis, which need prompt medical review.
A fever or sore throat that worsens despite the herb.
General note
The absence of reported oral toxicity reflects how little the oral root has been studied in controlled settings, not proof of safety. In the Hong Kong survey, most buyers were not even getting the plant the safety and pharmacology literature describes.
How Isatis Root Works
The mechanisms come from cell and animal studies of Isatis root and its isolated compounds. Very little is known about Strobilanthes root at the same level.
Goitrin and its precursors bind the virus, not the cell
In Nie's 2020 study, the four glucosinolate-derived compounds inhibited influenza by attaching to the viral envelope, without blocking the virus's adsorption to cells or its budding from them. The glucosinolates themselves need the enzyme myrosinase to become goitrin; how much further conversion happens after a person swallows them was not established in the sources located.
Goitrin is absorbed and distributed
In rats, goitrin from root extract was 56% bioavailable, lightly bound to plasma proteins, widely distributed (including to immune organs, liver, spleen and gut) and mainly excreted in urine. In the thyroid, goitrin's established action is to reduce thyroid hormone production; Felker's review describes inhibition of radioiodine uptake at the higher human dose.
Alkaloids and lignans damp inflammation
4(3H)-quinazolinone dampened the RIG-I viral-sensing pathway in mouse macrophages, reducing interferon-beta release. A 2025 study in the Journal of Ethnopharmacology identified root lignans absorbed into blood as selective inhibitors of COX-2, the inflammatory enzyme targeted by celecoxib. A 2026 mouse study (Phytomedicine) proposes that root alkaloids act through the aryl hydrocarbon receptor (AhR) against respiratory syncytial virus. AhR is also the receptor through which indigo naturalis promotes gut healing via interleukin-22, according to Naganuma's group.
Polysaccharides stimulate immune cells
The 2015 trial protocol cites mouse work in which root polysaccharides promoted interleukin-2 and interferon-gamma production and the proliferation of lymphocytes and macrophages. A purified Strobilanthes root polysaccharide of about 38.1 kDa reduced oxidative stress and inflammatory signaling in cells and animals in 2026.
The same extract can trigger pseudoallergy
The complement C3 activation that Gao's group traced to Isatis root extract offers one explanation, alongside the IgE findings in patients, for how a first-ever injection can produce an anaphylaxis-like reaction without prior sensitization. Whether oral doses do this to any meaningful degree is unknown.
Synergistic Supplements
No controlled trial has isolated what ban lan gen adds to a combination. The root appears in many Chinese patent formulas, including Lianhua Qingwen capsules, which were used for COVID-19 in China; no trial located shows what ban lan gen contributes to any benefit claimed for them. Pudilan, a four-herb extract that includes Isatis root, was entered into a 120-participant, 6-week trial of a mouthwash that also contains cetylpyridinium chloride, compared with chlorhexidine and with a placebo mouthwash (BMJ Open protocol, 2021). In US products, Isatis is sold alongside astragalus, echinacea and goldenseal without evidence that the pairings outperform either herb alone. The one combination with a documented downside is the Qingkailing injection, where the Isatis component was identified as the source of pseudoallergic reactions.
Interactions & What NOT to Take
No human interaction study or interaction case report involving oral Isatis root was located. The cautions below are inferences from its pharmacology, labeled as such.
Thyroid medicines and iodine status (inference)
Goitrin reduces thyroid iodine uptake at doses that a high-goitrin batch of root could plausibly supply. People taking levothyroxine, methimazole or propylthiouracil, or with low iodine intake, should not use ban lan gen regularly without their prescriber's knowledge.
Immunosuppressants (inference)
A root-derived compound combined with tacrolimus prolonged heart graft survival in mice, while the polysaccharides stimulate immune cells. Transplant recipients and people on drugs such as tacrolimus, cyclosporine or mycophenolate should avoid it.
Influenza antivirals (practical, not pharmacological)
There is no known chemical interaction with oseltamivir. The risk is substitution: using ban lan gen instead of an antiviral in someone who needs one.
Other injectable herbal products
Ban lan gen injection should never be mixed with other herbal injections. The Qingkailing data show that combining herbal extracts in an injection compounds the hypersensitivity risk.
Multi-herb products containing goldenseal
Products such as Isatis Gold add goldenseal, an herb with a drug-interaction profile of its own. Read the full ingredient list before combining any of these products with prescription medicines.
Quality, Testing & Adulteration
The substitution problem
Ngai and colleagues at the Chinese University of Hong Kong (PLoS One, 2025) bought ban lan gen and da qing ye in each of Hong Kong's 18 districts. Only 1 ban lan gen sample matched the pharmacopoeia's description by eye. DNA barcoding at several gene regions confirmed that 1 sample was Isatis, 17 were Strobilanthes (the genus was clear, the species not always), and one of the Strobilanthes samples also contained bai xian pi. HPLC told the same story: only the genuine sample showed the epigoitrin peak. For da qing ye, 1 of 19 samples was genuine, 16 were Strobilanthes, and 1 was Blumea balsamifera. One shop sold both genuine and substitute herbs in separate parcels and knew the difference. The authors attribute the substitution to a southern Chinese preference for Strobilanthes and note that Hong Kong is a major re-export hub for herbal material, so the problem may travel.
Substitution runs in both directions
The 2023 Chinese Medicine study reports the reverse problem in mainland manufacturing: because wild Strobilanthes root is scarce, its above-ground stems are collected and sometimes sold in its place, and Isatis root "has also been illegally used as a substitute" for the southern root in southern provinces. It counts 10 approved compound medicines containing the southern root and more than 200 companies approved to make them, 120 of which use it as the main ingredient in cold medicines. Jiemian reported that of 54 substandard batches of herbal slices announced in February 2017, 28 were ban lan gen.
Testing programs
No EU herbal monograph for Isatis was located. The usable reference standards are China's pharmacopoeia and the Hong Kong Chinese Materia Medica Standards.
What a complete certificate lists
The full Latin name with authority (Isatis indigotica Fort. or Isatis tinctoria L.), the plant part (root, not leaf, not mixed), country and province of origin, a DNA or macroscopic identity test, an HPLC result for (R,S)-goitrin or epigoitrin against the 0.020% (whole root, China), 0.030% (slices, China) or 0.029% (Hong Kong) limits, an extract ratio for extracts, and results for lead, cadmium, arsenic, mercury, pesticides, aflatoxins and sulfur dioxide against stated limits.
What a buyer can confirm
A pinyin name alone ("ban lan gen") is ambiguous. Look for a Latin species name and a plant part.
"Isatis extract leaf and root" means a mixture of da qing ye and ban lan gen in unknown proportion.
With loose slices, Hong Kong's Department of Health describes Isatis root slices as round, slightly soft and without a central pith, with yellowish-white to yellowish-brown bark and a yellow core, and Strobilanthes slices as oblique, elliptical, hard and brittle, with a bluish-gray rind and a pith in rhizome pieces.
A product claiming to treat influenza or COVID-19 should not be bought.
Special Considerations
Two plants, two SARS claims
The 2015 trial protocol states that ban lan gen was one of eight medicines recommended by the Chinese government for preventing and controlling SARS. The 2023 study of the southern root states that nan ban lan gen was one of eight antiviral herbs used during the SARS epidemic. Each literature claims the episode for its own plant, which says as much about the naming problem as about either root.
Regulatory and policy history in China
Jiemian's 2022 report, which this issue could not check against every original document, states that China's influenza treatment guideline stopped including ban lan gen in November 2018, and that urban retail pharmacy sales in 2019 were 1.065 billion yuan for ban lan gen granules and 430 million yuan for compound granules. In October 2020, in vitro results for a compound ban lan gen granule against the COVID-19 virus were announced, and the manufacturer stressed they were laboratory results only; Jiemian found no COVID-19 clinical trial of ban lan gen in China's trial registry.
The relative with a human hazard record
Indigo naturalis (qing dai) is not the root, but it is made from the leaves and stems of Strobilanthes cusia, Polygonum tinctorium or Isatis indigotica, so it sits close by on Chinese medicine shelves. In Naganuma's 2018 Japanese trial, 8 weeks of 0.5 to 2.0 g a day produced clinical responses in 69.6% to 81.0% of ulcerative colitis patients against 13.6% on placebo, but the trial was halted after the pulmonary arterial hypertension report, and the authors concluded it "should not yet be used" because of adverse effects including pulmonary arterial hypertension. Do not self-purchase indigo naturalis, for ulcerative colitis or anything else.
United States status
Isatis root reaches US shelves as a dietary supplement, which means FDA does not review its safety or effectiveness before sale.
Research Status & Evidence Quality
Tier 1, identity and chemistry (strongest)
Pharmacopoeia definitions, the Hong Kong standards, the 2023 comparative profiling of the two roots and the 2025 DNA survey are consistent: the two plants are chemically distinct, the official marker separates them, and market substitution is common in at least one major trading hub.
Tier 2, one small human trial
You and colleagues (2009): 20 patients, radiation mucositis, gargle-and-swallow preparation, positive on symptom scores and interleukin-6, with plant authentication not described in the abstract. It is not a basis for using the herb during radiotherapy outside the oncology team's care.
Tier 3, registered but unreported
The Guangzhou influenza trial (NCT02232945): planned 177, 50 completed by June 2014, industry-sponsored, no results posted after the record's last update in March 2016.
Tier 4, animal, veterinary and cell studies
Antiviral activity of isolated compounds against influenza, herpes simplex, coxsackie and respiratory syncytial viruses; immune effects of polysaccharides in poultry and other animals; rat pharmacokinetics of goitrin; complement activation in mice and human serum.
Research Limitations
No human pharmacokinetic study, no human thyroid study, no reproductive or pediatric safety study, and no published placebo-controlled efficacy result for oral ban lan gen were located. Goitrin content varies about 20-fold between published measurements. Many laboratory papers do not report how plant material was authenticated, and in the one market survey located, 17 of 18 retail samples were the other plant. Much of the clinical literature on Chinese patent medicines tests multi-herb formulas, which cannot show what the root contributes.
Summary & Key Takeaways
Bottom Line
Isatis root (ban lan gen) is the dried root of a cabbage-family plant, Isatis indigotica, sold under a name it shares with the unrelated Strobilanthes cusia root; in a 2025 Hong Kong survey, 17 of 18 retail samples were Strobilanthes. Its antiviral reputation rests on cell and egg studies of isolated compounds, one 20-patient mucositis trial and an industry influenza trial that never reported results. Its marker compound, goitrin, is an antithyroid substance whose content varies about 20-fold between published measurements.
Key Safety Points
Do not use ban lan gen in place of an antiviral for influenza, especially in high-risk people.
Ban lan gen injection carries an anaphylactic shock warning in China and belongs only in a medical facility.
Avoid it in pregnancy, while breastfeeding and in young children without a clinician, since no safety data exist.
People with thyroid disease, low iodine intake or on thyroid medication should not use it regularly.
Indigo naturalis (qing dai), made from related plants, has been linked to pulmonary arterial hypertension; its trial authors said it should not yet be used. Do not self-purchase it.
One Hong Kong ban lan gen sample contained bai xian pi, an herb linked to liver injury.
Special Note
A label that says only "ban lan gen" or "Isatis extract leaf and root" does not tell you which plant, which part or how much goitrin you are buying. The evidence for Isatis root applies only to Isatis root, and on the market survey located for this issue, that is not a safe assumption to make about a bag bought by its Chinese name.
Forwarded this, or reading it on the web? to get the next breakdown.
Researched and drafted with AI assistance. Every claim verified against primary sources and human-reviewed before publication. Last reviewed: November 14, 2026. Corrections: reply to any issue.
This issue is general information, not medical advice. If you are pregnant or breastfeeding, have thyroid disease, take thyroid medication or immunosuppressants, have a flu-like illness and a higher risk of complications, or are considering ban lan gen for a child, talk to a qualified clinician before starting, stopping or changing any supplement or medication.
Is Isatis Root safe? Common questions
Is Isatis Root safe for everyone?
Who may consider it: No group has been shown in a published, adequately sized trial to benefit from ban lan gen. The realistic users are: Adults using Chinese medicine under a trained practitioner for a short course during a sore throat or feverish cold, who… Who should avoid it: Contraindications Ban lan gen injection outside a hospital setting. In November 2022 China's National Medical Products Administration ordered its label to warn that adverse reactions include anaphylactic shock, that it…
What are possible side effects of Isatis Root?
Injection China's regulator required ban lan gen injection labels to state that adverse reactions include anaphylactic shock, according to the November 2022 Jiemian report of the announcement. The mechanism has been studied in a related product. Gao and colleagues (2019) traced the immediate hypersensitivity reactions of Qingkailing injection, a…
Does Isatis Root interact with medications or other supplements?
No human interaction study or interaction case report involving oral Isatis root was located. The cautions below are inferences from its pharmacology, labeled as such. Thyroid medicines and iodine status (inference) Goitrin reduces thyroid iodine uptake at doses that a high-goitrin batch of root could plausibly supply. People taking levothyroxine…
The Nutrient Wise app checks Isatis Root against the medications you take and warns you before you scan a supplement that could interact. It is free to start (5 scans a month, no card): App Store · Google Play.
Medical disclaimer: This page is informational, not medical advice. Talk to a licensed healthcare provider before starting any supplement, especially if you take medications or have a chronic condition. See our privacy policy for how we handle your data inside the app.